ClinicalTrials.gg
CompletedNCT04202276Updated Feb 8, 2022

The Study of Nutrition of Children and Adolescents With GERD

An interventional study of diet assessment in GERD in Children and GERD, sponsored by Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology. Completed at 1 site in Russian Federation. Open to participants aged 6 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-02-08.

Sponsored by Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Registered 2 years 11 months after the study started (first participant enrolled Jan 2017, registered Dec 2019).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
219
Allocation
Non-randomized
Ages
6 Years to 17 Years
Sex
All
01

Study summary

This trial is to study the aspects of nutrition in children and adolescents with GERD compared to the sex and age-matched control group

Read the detailed description

The aim of the study is to assess the differences in nutrition of pediatric patients with GERD compared to the control group. The secondary aim is to study possible associations of the data on nutritional habits revealed with the use of food frequency questionnaire (FFQ) and the data of 24-hours oesophageal pH-impedance examination.

02

Conditions studied

  • GERD in Children
  • GERD

Keywords

  • gastroesophageal reflux
  • weight
  • obesity
  • nutrition
  • GERD
  • esophageal pH-impedance
  • food frequency questionnair
03

In context

Gastroesophageal Reflux

1,216 studies on the registry are indexed under Gastroesophageal Reflux; 204 are open to participants now.

This study's enrollment of 219 is above the median of 68 across 800 interventional studies indexed under Gastroesophageal Reflux.

Browse Gastroesophageal Reflux studies →

Lead sponsor

Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Willingness to participate (written and consent from parents or legal representative according to the local law);
  • Age 6 to 17 years old inclusive,
  • Possibility to assess symptoms, data of the medical history and receive answers to the questions about usual diet.

Exclusion criteria

Exclusion Criteria:

  • history of abdominal surgery;
  • presence of varicose veins of the stomach and/or the oesophagus either in medical history or found during the study;
  • inability to tolerate at least one of the invasive procedures or lacking data of the other instrumental examinations required by protocol;
  • general condition of the patient making impossible to perform all the examinations or when performing the procedures is not safe and reasonable based on the opinion of the investigator that it may exacerbate the disease flow or put the patient at risk;
  • intake of medications which may influence the clinical and instrumental data, including, but not limited to: non- anti-inflammatory agents, glucocorticosteroids (except for skin products, if they were used for 2 weeks or less at the time of inclusion into the study), medications affecting adrenergic, acetylcholine receptors, antidepressants, tranquillizers, sedatives, those with known local irritant effect on the gastrointestinal tract mucosa; the use of proton pump inhibitors and H2 receptors blockers are not allowed during the study, a for at least 2 weeks is necessary before the enrolment.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Washout period

A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
219 participants (actual)

Study arms

  • Other
    Patients with GERD

    The data of Food frequency questionnaire (FFQ), 24-hours oesophageal pH-impedance examination, GERD-Q questionnaire to be performed in children and adolescents with GERD.

    Other: diet assessment

  • Other
    Control group

    The same examinations as in experimental group are to be performed in patients of the control group (no GERD according to the results of the examination): Food frequency questionnaire (FFQ), 24-hours oesophageal pH-impedance examination, GERD-Q questionnaire.

    Other: diet assessment

Interventions

  • Otherdiet assessment

    Food frequency questionnaire to investigate differences in diet of children and adolescents with GERD compared to the age- and sex matched control group.

06

What researchers measure

Primary outcomes

  1. Energy value of the ration

    value of mean daily consumption of the energy by food frequency questionnaire, kcal/day

    Time frame: An average of 1 year

  2. total fat consumption

    value of mean daily consumption of fats by food frequency questionnaire, G/day

    Time frame: An average of 1 year

  3. total carbohydrate consumption

    value of mean daily consumption of carbohydrates, by food frequency questionnaire, G/day

    Time frame: An average of 1 year

  4. total protein consumption

    value of mean daily consumption of protein by food frequency questionnaire, G/day

    Time frame: An average of 1 year

  5. Dietary fibre consumption

    value of mean daily consumption of dietary fibre, by food frequency questionnaire, G/day

    Time frame: An average of 1 year

Secondary outcomes

  1. Total number of gastroesophageal refluxes

    This measure is to be obtained by 24-hours oesophageal pH-impedance study

    Time frame: 24-hours

  2. Number of acid gastroesophageal refluxes

    This measure is to be obtained by 24-hours oesophageal pH-impedance study

    Time frame: 24-hours

  3. Number of weak-acid gastroesophageal refluxes

    This measure is to be obtained by 24-hours oesophageal pH-impedance study

    Time frame: 24-hours

  4. Number of high gastroesophageal refluxes

    This measure is to be obtained by 24-hours oesophageal pH-impedance study

    Time frame: 24-hours

  5. Acid exposure time

    This measure is to be obtained by 24-hours oesophageal pH-impedance study

    Time frame: 24-hours

07

Study locations

1 site
  • Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
    Moscow, 115446, Russian Federation
08

References and documents

Publications

  • Borodina G, Morozov S. Children With Gastroesophageal Reflux Disease Consume More Calories and Fat Compared to Controls of Same Weight and Age. J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):808-814. doi: 10.1097/MPG.0000000000002652. PubMed 32443037 ↗

Individual participant data

Plan to share: Yes — Data may be shared by the request. No personal data of the participants is a subject for sharing.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: upon study completion. Available for 2 years according to the local low

Access criteria: by request

Data sharing details ↗ · rosrid.ru

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2017 to primary completion in Jun 2019, 29 months.

Of 194 non-industry interventional studies with no phase under Gastroesophageal Reflux, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 68. This study's 29 months is close to that.

Counting every sponsor, half of 228 studies reached it within 32 months; a quarter within 12 and three quarters within 68.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 15, 2019
First posted
Dec 17, 2019
StartActual
Jan 1, 2017
Primary completionActual
Jun 30, 2019
CompletionActual
Dec 31, 2021
Last update
Feb 8, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04202276
Lead sponsor
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Responsible party
Sergey Morozov (Leading researcher, Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology) — Principal investigator
First posted
Dec 17, 2019
Start date
Jan 1, 2017
Primary completion
Jun 30, 2019
Completion
Dec 31, 2021
Last update
Feb 8, 2022

Study contacts

Dmitriy B Nikityuk, Professor
study director · Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Tatiana Strokova, Professor
study chair · Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion